Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) EBIT Margin (2022 - 2025)

Historic EBIT Margin for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to 309.02%.

  • Cannabis Bioscience International Holdings' EBIT Margin fell 2544600.0% to 309.02% in Q3 2025 from the same period last year, while for Aug 2025 it was 268.68%, marking a year-over-year decrease of 1611200.0%. This contributed to the annual value of 139.05% for FY2025, which is 563100.0% up from last year.
  • Per Cannabis Bioscience International Holdings' latest filing, its EBIT Margin stood at 309.02% for Q3 2025, which was down 2544600.0% from 385.91% recorded in Q2 2025.
  • Cannabis Bioscience International Holdings' 5-year EBIT Margin high stood at 39.06% for Q2 2024, and its period low was 865.54% during Q1 2025.
  • Its 4-year average for EBIT Margin is 327.94%, with a median of 275.89% in 2023.
  • As far as peak fluctuations go, Cannabis Bioscience International Holdings' EBIT Margin soared by 5532400bps in 2024, and later plummeted by -4261900bps in 2025.
  • Cannabis Bioscience International Holdings' EBIT Margin (Quarter) stood at 222.34% in 2022, then skyrocketed by 33bps to 148.26% in 2023, then skyrocketed by 46bps to 80.31% in 2024, then plummeted by -285bps to 309.02% in 2025.
  • Its EBIT Margin was 309.02% in Q3 2025, compared to 385.91% in Q2 2025 and 865.54% in Q1 2025.